Outcomes of Patients With Multidrug-Resistant Pulmonary Tuberculosis Treated With Ofloxacin/Levofloxacin-Containing Regimens
Authors:
- Chi Kuen ChanCCChi Kuen Chan
- Chi Hung ChauCCChi Hung Chau
- Cheuk Ming TamCTCheuk Ming Tam
- Chi Chiu LeungCLChi Chiu Leung
- Poon Chuen WongPWPoon Chuen Wong
- Joseph LeeJLJoseph Lee
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Randomized Controlled Trial of a Drug Regimen That Includes Ciproftoxacin for the Treatment of Pulmonary TuberculosisClinical Infectious Diseases, 1996
- Epidemiology, Control and Treatment of Multidrug-Resistant TuberculosisDrugs, 1996
- Treatment of Multidrug-Resistant TuberculosisNew England Journal of Medicine, 1993
- Ofloxacin-Based Chemotherapy in Multiply Drug-Resistant Pulmonary TuberculosisDrugs, 1993
- Prospective Comparative Study of Ofloxacin or Ethambutol for the Treatment of Pulmonary TuberculosisChest, 1992
- A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicinTubercle and Lung Disease, 1992
- In-vitro activity of ofloxacin against Mycobacterium tuberculosis and its clinical efficacy in multiply resistant pulmonary tuberculosisJournal of Antimicrobial Chemotherapy, 1990
- In vitro activity of four fluoroquinolones against eighty-six isolates of mycobacteriaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosisJournal of Antimicrobial Chemotherapy, 1987
- In-vitro susceptibility of mycobacteria to ciprofloxacinJournal of Antimicrobial Chemotherapy, 1985